Gordon, K.; Warren, R.; Gottlieb, A.; Blauvelt, A.; Thaci, D.; Leonardi, C.; Poulin, Y.; Boehnlein, M.; Kavanagh, S.; Arendt, C.; Reich, K. Certolizumab Pegol for Treatment of Plaque Psoriasis: Pooled Three-Year Efficacy Outcomes from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2). J of Skin 2019, 3, S37.